PMN310 is a monoclonal antibody targeting beta-amyloid oligomers (AbetaO). It prevents AbetaO-induced memory formation loss in vivo and reduces synaptic loss and inflammation. PMN310 is applicable in Alzheimers disease research.
Target:
Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted
